All Facilities , From 2026-05-18 - 2026-05-31
AMR INDICATOR 3 :: Drug Resistance
n = 255 Number of Isolates
All Specimens All Organisms
n = 255 Number of Isolates
All Specimens All Organisms
| Anntibiotic | Total Tested | Number Resistance | % Resistance |
|---|---|---|---|
| Voriconazole | 11 | 1 | 9.1 |
| Ampicillin | 70 | 60 | 85.7 |
| Penicillin G | 50 | 39 | 78.0 |
| Oxacillin | 15 | 11 | 73.3 |
| Cefuroxime | 91 | 65 | 71.4 |
| Ceftriaxone | 126 | 89 | 70.6 |
| Erythromycin | 70 | 49 | 70.0 |
| Tetracycline | 89 | 62 | 69.7 |
| Trimethoprim | 16 | 11 | 68.8 |
| Trimethoprim/Sulfamethoxazole | 134 | 86 | 64.2 |
| Caspofungin | 8 | 5 | 62.5 |
| Cefoxitin | 37 | 23 | 62.2 |
| Cefotaxime | 77 | 47 | 61.0 |
| Fluconazole | 7 | 4 | 57.1 |
| Ciprofloxacin | 207 | 118 | 57.0 |
| Ceftazidime | 120 | 64 | 53.3 |
| Gentamicin | 167 | 84 | 50.3 |
| Ceftolozane-tazobactam | 2 | 1 | 50.0 |
| Piperacillin | 8 | 4 | 50.0 |
| Azithromycin | 14 | 7 | 50.0 |
| Micafungin | 8 | 4 | 50.0 |
| Amoxicillin/ Clavulanic acid | 55 | 27 | 49.1 |
| Nalidixic acid | 29 | 14 | 48.3 |
| Ampicillin/ Sulbactam | 11 | 5 | 45.5 |
| ertapenem | 9 | 4 | 44.4 |
| Kanamycin | 5 | 2 | 40.0 |
| Cefepime | 69 | 25 | 36.2 |
| Levofloxacin | 59 | 21 | 35.6 |
| Clindamycin | 80 | 27 | 33.8 |
| Aztreonam | 27 | 9 | 33.3 |
| Teicoplanin | 3 | 1 | 33.3 |
| Doxycycline | 41 | 13 | 31.7 |
| Piperacillin/Tazobactam | 131 | 37 | 28.2 |
| Chloramphenicol | 112 | 30 | 26.8 |
| Amoxicillin | 4 | 1 | 25.0 |
| Nitrofurantoin | 104 | 24 | 23.1 |
| Amphotericin B | 9 | 2 | 22.2 |
| Rifampin | 9 | 2 | 22.2 |
| Tigecycline | 5 | 1 | 20.0 |
| Amoxicillin/Clavulanic acid | 6 | 1 | 16.7 |
| Amikacin | 82 | 13 | 15.9 |
| Meropenem | 91 | 14 | 15.4 |
| Linezolid | 40 | 6 | 15.0 |
| Imipenem | 112 | 13 | 11.6 |
| Vancomycin | 54 | 6 | 11.1 |
| Cefazolin | 4 | 4 | 100.0 |
| Cefotaxim | 9 | 9 | 100.0 |